Onyx Pharmaceuticals - PDFSEARCH.IO - Document Search Engine

Onyx Pharmaceuticals
Results: 23

#	Item
11	ODAC Briefing Document NDA[removed] Add to Reading List Source URL: www.fda.gov Language: English Carfilzomib Epoxides Morpholines Immunosuppressants Bortezomib Lenalidomide Onyx Pharmaceuticals Proteasome inhibitor Multiple myeloma Medicine Chemistry Organic chemistry
12	NDA[removed]Carfilzomib (Kyprolis™) June 20, 2012 Oncologic Drugs Advisory Committee Thomas Herndon, M.D. Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Carfilzomib Epoxides Morpholines Bortezomib Proteasome inhibitor Lenalidomide Multiple myeloma Onyx Pharmaceuticals Chemistry Medicine Organic chemistry
13	Nexavar® (sorafenib) for Kidney Cancer Nexavar is a medication used to treat advanced kidney cancer in adults Dosage: 400mg twice a day How supplied: 200mg tablets Storage: Room temperature. Route of Administration: Nex Add to Reading List Source URL: www.kidneycancer.org Language: English - Date: 2014-01-19 16:05:22 Kidney cancer Organochlorides Organofluorides Amides Pyridines Sorafenib Hepatocellular carcinoma Onyx Pharmaceuticals Vomiting Medicine Chemistry Organic chemistry
14	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Drug Evaluation and Research Onyx Pharmaceuticals New Drug Application Carfilzomib Oncology Drug Advisory Committee Food and Drug Administration Pharmaceutical sciences Pharmacology
15 $Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Application for the Treatment of Radioactive Iodine-Refractory Differentiated Thyroid Cancer Whippany$	Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Application for the Treatment of Radioactive Iodine-Refractory Differentiated Thyroid Cancer Whippany Add to Reading List Source URL: www.thyroid.org Language: English - Date: 2013-11-08 16:26:51 Organofluorides Pyridines Amides Organochlorides Sorafenib Onyx Pharmaceuticals Renal cell carcinoma Hepatocellular carcinoma Thyroid cancer Chemistry Medicine Organic chemistry
16	September 10, 2013 The Honorable John Boehner Speaker United States House of Representatives Washington, D.C[removed]The Honorable Nancy Pelosi Add to Reading List Source URL: www.hrpolicy.org Language: English - Date: 2013-09-09 13:08:13 Chief human resources officer Japan America Student Conference Onyx Pharmaceuticals Management SRA International Humana
17	MULTIPLE MYELOMA RESEARCH FOUNDATION DONOR PROGRESS REPORT[removed]POWERFUL THINKING ADVANCES THE CURE Add to Reading List Source URL: www.themmrf.org Language: English - Date: 2013-12-17 11:09:54 Cancer organizations Norwalk Connecticut Multiple Myeloma Research Foundation Multiple Myeloma Research Consortium Kathy Giusti Bortezomib Carfilzomib Multiple myeloma Onyx Pharmaceuticals Medicine Oncology Cancer research
18	PSIOXUS THERAPEUTICS STRENGTHENS TEAM WITH TWO APPOINTMENTS Addition of Non-Executive Board Director and Expanded Scientific Advisory Board Position Development Stage Biotech for Growth and Commercialisation LONDON – 1 Add to Reading List Source URL: www.psioxus.com Language: English - Date: 2012-01-18 05:15:55 Viruses GlaxoSmithKline Onyx Pharmaceuticals Biologic Pharmaceutical industry Oncologists Medicine Biotechnology Oncolytic virus
19	PDF Document Add to Reading List Source URL: www.oncotyrol.at Language: English - Date: 2014-05-15 07:53:27 Onyx Pharmaceuticals Cancer research American Association for Cancer Research David A. Wood Cancer Head and neck cancer Medicine Cancer organizations University of California San Francisco
20	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Biology Chemistry Organic chemistry Proteasome inhibitor Onyx Pharmaceuticals Multiple myeloma Proteasome Bortezomib Proteolix Carfilzomib Epoxides Morpholines